Guardant Health, Inc. (GH)
NASDAQ · Services · Services-medical laboratories
$177.25+$0.8000 (+0.45%) on the dayAs of the close; data may be delayed.
GH price, last 12 months
Key stats
- Previous close
- $176.45
- Open
- $178.50
- Day range
- $174.50 – $179.97
- 52-week range
- $58.74 – $183.51
- Volume
- 1.6M
- Avg volume (20 days)
- 1.9M
- Market cap
- $23.8B
Performance
1W−1.2%
1M+3.7%
3M+18.8%
6M+101.2%
YTD+73.5%
1Y+207.4%
vs S&P 500, 1Y+190.6 pts
Technicals and fundamentals
About Guardant Health, Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
- Sector
- Services
- Industry
- Services-medical laboratories
- Listed on
- NASDAQ
- Market cap
- $23.8B